Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer.
Saved in:
| Title: | Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer. |
|---|---|
| Authors: | Anton A; Walter and Eliza Hall Institute, Melbourne, Vic., Australia., Kamel Hasan O; Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada., Ballok Z; Healthcare Imaging Services, Melbourne, Vic., Australia., Bowden P; ICON Cancer Care, Melbourne, Vic., Australia., Costello AJ; Royal Melbourne Hospital, Melbourne, Vic., Australia.; Australian Prostate Centre, Melbourne, Vic., Australia., Harewood L; Royal Melbourne Hospital, Melbourne, Vic., Australia.; Epworth Healthcare, Melbourne, Vic., Australia.; Department of Surgery, University of Melbourne, Melbourne, Vic., Australia., Corcoran NM; Royal Melbourne Hospital, Melbourne, Vic., Australia.; Australian Prostate Centre, Melbourne, Vic., Australia.; Department of Surgery, University of Melbourne, Melbourne, Vic., Australia., Dundee P; Royal Melbourne Hospital, Melbourne, Vic., Australia.; Australian Prostate Centre, Melbourne, Vic., Australia., Peters JS; Royal Melbourne Hospital, Melbourne, Vic., Australia., Lawrentschuk N; Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Epworth Healthcare, Melbourne, Vic., Australia., Troy A; Epworth Healthcare, Melbourne, Vic., Australia., Webb D; Epworth Healthcare, Melbourne, Vic., Australia., Chan Y; Epworth Healthcare, Melbourne, Vic., Australia., See A; ICON Cancer Care, Melbourne, Vic., Australia., Siva S; Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; ICON Cancer Care, Melbourne, Vic., Australia., Murphy D; Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic., Australia., Hofman MS; Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic., Australia., Tran B; Walter and Eliza Hall Institute, Melbourne, Vic., Australia.; Peter MacCallum Cancer Centre, Melbourne, Vic., Australia.; Epworth Healthcare, Melbourne, Vic., Australia. |
| Source: | BJU international [BJU Int] 2020 Oct; Vol. 126 (4), pp. 433-435. Date of Electronic Publication: 2020 Aug 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1464-410X |
|---|---|
| DOI: | 10.1111/bju.15151 |
